ESC 365 - Impact of baseline hemoglobin level and white blood cell count in real-world patients undergoing contemporary percutaneous coronary intervention: insights from the GLOBAL LEADER study

ESC Premium Access

Impact of baseline hemoglobin level and white blood cell count in real-world patients undergoing contemporary percutaneous coronary intervention: insights from the GLOBAL LEADER study

Session: Optimal treatment of coronary artery disease

Topic: Comorbidities

Speaker: Doctor P. Chichareon (Hat Yai, TH)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Ply Chichareon

Prince of Songkla University, Hat Yai (Thailand)

0 follower

4 more presentations in this session

Exercise training ameliorates vasodilator capacity of coronary microvessels in patients with vasospastic angina -A new therapeutic approach for the coronary functional disorder-

Speaker: Doctor J. Sugisawa (Sendai, JP)

Contemporary mortality rates in myocardial infarction patients in Sweden: a tale of two registries

Speaker: Mr J. Siverskog (Linkoping, SE)

Updated meta-analysis of biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent implantations

Speaker: Doctor J. Choe (Pusan, KR)

First-line coronary computed tomography predicts long-term clinical outcome in patients with Non-ST-segment elevation acute coronary syndrome - The VERDICT trial

Speaker: Associate Professor K. Kofoed (Copenhagen, DK)

Access the full session

Optimal treatment of coronary artery disease

Speakers: Doctor P. Chichareon, Doctor J. Sugisawa, Mr J. Siverskog, Doctor J. Choe, Associate Professor K. Kofoed

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources